• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    OHA is Administrative Agent and Lead Left Arranger of Private Debt Financing Supporting Montagu's Acquisition of Tyber Medical

    6/18/25 8:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance
    Get the next $TROW alert in real time by email

    New York, New York, June 18, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors ("OHA") served as Administrative Agent and Lead Left Arranger for the private senior debt financing supporting the acquisition of Tyber Medical, LLC ("Tyber Medical") by Montagu Private Equity ("Montagu"). Tyber Medical is a leading orthopedic device manufacturer serving the spine and trauma end markets.

    As part of the transaction, Montagu will merge Tyber Medical with two of its existing portfolio companies, Resolve Surgical Technologies ("Resolve") and Intech Medical ("Intech"), to create a scaled contract development and manufacturing organization ("CDMO") offering end-to-end services that span product conceptualization, development, manufacturing and regulatory approval for advanced surgical systems. OHA is one of the largest holders across the new first lien facility.

    OHA's comprehensive understanding of CDMOs, having invested in several leading private and public companies within the market, positioned it to diligence the financing opportunity with speed and certainty.

    "We are pleased to partner with Montagu as a leading investment firm with a proven track record of investing across the healthcare ecosystem and driving growth within its portfolio companies," said Eric Muller, Partner and Portfolio Manager at OHA. "Our deep history of investing in CDMOs allowed us to quickly gain conviction in each of Tyber Medical, Resolve and Intech, and we look forward to supporting the accelerated advancements within orthopedics that we believe will be driven by the scale and domain expertise of the combined business."

    "We are delighted to establish this new debt financing and to partner with our lender group, led by OHA," said Henry Johnson, Partner and Head of Capital Markets at Montagu. "The transaction will support the business's strategic initiatives and represents another successful capital markets execution in the U.S. for Montagu."

    Rothschild & Co served as financial advisor to Montagu for the debt financing transaction.

    BMO Capital Markets also participated in this financing as OHA's private credit joint venture partner.

    ###

    About OHA: Oak Hill Advisors (OHA) is a leading global credit-focused alternative asset manager with over 30 years of investment experience. OHA works with institutions and individuals and seeks to deliver a consistent track record of attractive risk-adjusted returns. The firm has approximately $95 billion in assets under management (AUM) across credit strategies, including private credit, high yield bonds, leveraged loans, private capital solutions and collateralized loan obligations as of March 31, 2025. Additional information on OHA's AUM calculation methodology can be found on the OHA website. OHA's emphasis on long-term partnerships with companies, sponsors and other partners allows for the provision of customized credit solutions across market cycles.

    With over 400 experienced professionals across six global offices, OHA brings a collaborative approach to offering investors a single platform to meet their diverse credit needs. OHA is the private markets platform of T. Rowe Price Group, Inc. (NASDAQ – GS: TROW). For more information, please visit www.oakhilladvisors.com.

    About Tyber Medical, LLC: Tyber Medical, LLC is a leading orthopedic device manufacturer providing rapid access to FDA-cleared and CE-marked, private label, portfolio-enhancing regulatory-approved orthopedic implants for the spinal, extremity, and trauma markets. Since its founding in 2012, the company has released more than 50 spine, extremity, and trauma systems. Tyber Medical aims to develop and utilize differentiated bioengineered technologies, including surface treatments and coatings, to advance orthopedic science. For more information, visit https://tybermedical.com.

    About Montagu: Montagu is a leading mid-market private equity firm, committed to finding and growing businesses that make the world work. Focusing on businesses with a must-have product or service in a structurally growing marketplace, Montagu brings proven growth capabilities to help companies achieve their ambitions and unlock their full potential. Montagu specializes in carve-out and other first time buyout investments and has deep expertise in five priority sectors: Healthcare, Financial Sector Services, Critical Data, Digital Infrastructure and Education. ESG forms an integral part of its strategy, and its commitment to responsible investment is fully integrated into its investment and value-creation process. Montagu partners with companies with enterprise values between €200 million and €1 billion and has €14 billion of assets under management.



    Natalie Harvard, Head of Investor Relations & Partner
    Oak Hill Advisors, L.P.
    212-326-1505
    [email protected]
    
    Kristin Celestino, Vice President, Branding
    Oak Hill Advisors, L.P.
    817-215-2934
    [email protected]
    
    Get the next $TROW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TROW

    DatePrice TargetRatingAnalyst
    9/12/2024$109.00Equal Weight
    Wells Fargo
    8/27/2024$99.00Underweight
    Barclays
    4/11/2024$106.00 → $120.00Underperform → Mkt Perform
    Keefe Bruyette
    4/8/2024$92.00 → $114.00Sell → Hold
    TD Cowen
    1/8/2024$95.00 → $105.00Equal Weight → Underweight
    Wells Fargo
    1/4/2024$88.00Underperform
    TD Cowen
    10/31/2023$100.00 → $95.00Sell → Neutral
    Citigroup
    5/19/2023$98.00Sell
    Citigroup
    More analyst ratings

    $TROW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Vice President Page Sebastien exercised 17,059 shares at a strike of $69.02 and covered exercise/tax liability with 14,300 shares, increasing direct ownership by 4% to 64,375 units (SEC Form 4)

      4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

      6/20/25 9:49:08 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • VP Sawyer Dorothy C sold $190,860 worth of shares (2,000 units at $95.43), decreasing direct ownership by 4% to 44,789 units (SEC Form 4)

      4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

      6/12/25 9:20:18 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • VP Sawyer Dorothy C was granted 78 shares and gifted 267 shares, decreasing direct ownership by 0.40% to 46,789 units (SEC Form 4)

      4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

      6/5/25 10:26:28 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    SEC Filings

    See more
    • SEC Form 144 filed by T. Rowe Price Group Inc.

      144 - PRICE T ROWE GROUP INC (0001113169) (Subject)

      5/13/25 9:39:46 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. Rowe Price Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - PRICE T ROWE GROUP INC (0001113169) (Filer)

      5/12/25 9:24:54 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form 10-Q filed by T. Rowe Price Group Inc.

      10-Q - PRICE T ROWE GROUP INC (0001113169) (Filer)

      5/2/25 11:44:44 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OHA is Administrative Agent and Lead Left Arranger of Private Debt Financing Supporting Montagu's Acquisition of Tyber Medical

      New York, New York, June 18, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors ("OHA") served as Administrative Agent and Lead Left Arranger for the private senior debt financing supporting the acquisition of Tyber Medical, LLC ("Tyber Medical") by Montagu Private Equity ("Montagu"). Tyber Medical is a leading orthopedic device manufacturer serving the spine and trauma end markets. As part of the transaction, Montagu will merge Tyber Medical with two of its existing portfolio companies, Resolve Surgical Technologies ("Resolve") and Intech Medical ("Intech"), to create a scaled contract development and manufacturing organization ("CDMO") offering end-to-end services that span product conceptua

      6/18/25 8:00:00 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER

      The T. Rowe Price Financials ETF, Health Care ETF and Natural Resources ETF began trading today and expanded the firm's ETF lineup to 22 BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds (ETF): T. Rowe Price Financials ETF (Ticker: TFNS), T. Rowe Price Health Care ETF (Ticker: TMED), and T. Rowe Price Natural Resources ETF (Ticker: TURF). The new funds began trading on NASDAQ today. T. Rowe Price's active ETF roster now sits at 22 offerings.

      6/12/25 10:05:00 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. ROWE PRICE RELEASES 2025 MIDYEAR INVESTMENT OUTLOOK

      Investing in a post-globalization world with reconfigured global trade necessitates a careful assessment of market opportunities and risks BALTIMORE, June 9, 2025 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, released its midyear outlook for global financial markets for the remainder of 2025. Underpinning the outlook for the next six months is an accelerated trend toward deglobalization, a tariff-driven reconfiguration of global trade, an expected broadening of stock market opportunities globally beyond U.S. equities and mega-cap tech stocks, and a bond market regime change driven by trade policy changes and German fiscal expansion.

      6/9/25 1:00:00 PM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on T. Rowe Price with a new price target

      Wells Fargo initiated coverage of T. Rowe Price with a rating of Equal Weight and set a new price target of $109.00

      9/12/24 9:14:34 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • Barclays initiated coverage on T. Rowe Price with a new price target

      Barclays initiated coverage of T. Rowe Price with a rating of Underweight and set a new price target of $99.00

      8/27/24 7:37:56 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. Rowe Price upgraded by Keefe Bruyette with a new price target

      Keefe Bruyette upgraded T. Rowe Price from Underperform to Mkt Perform and set a new price target of $120.00 from $106.00 previously

      4/11/24 8:03:23 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance